Spina bifida: MRC folate trials to start at last.
D002986:Clinical Trials as Topic; D035061:Control Groups; D030881:Disclosure; D004311:Double-Blind Method; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D009436:Neural Tube Defects / Q000517:prevention & control*; D011247:Pregnancy; D037841:Pregnant People; D018570:Risk Assessment; D016136:Spina Bifida Occulta / Q000517:prevention & control*
D005492:Folic Acid